Hereditary paraganglioma targets diverse paraganglia

Journal of Medical Genetics

Volumn 39, Issue 9, 2002, Pages 617-622

  Baysal, B E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ABDOMEN; ADRENAL MEDULLA; CANCER GENETICS; CANCER INCIDENCE; CANCER PATIENT; CARCINOGENESIS; CAROTID ARTERY BIFURCATION; CAROTID BODY; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; GERM LINE; HEAD AND NECK CANCER; HUMAN; MITOCHONDRION; MULTIPLE CANCER; NEUROENDOCRINE SYSTEM; PARAGANGLIOMA; PELVIS FLOOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SKULL BASE; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

EID: 0036712593     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.39.9.617     Document Type: Review

References (82)

1. Anatomy and physiology of peripheral arterial chemoreceptors
2. Anatomy and topography
3. Regulation of oxygen sensing in peripheral arterial chemoreceptors
4. Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance
5. Genetics of familial paragangliomas: Past, present, and future
6. Stress-triggered activation of gene expression in catecholaminergic systems: Dynamics of transcriptional events
7. Nonneurogenic hypoxia sensitivity in rat adrenal slices
8. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC 12) cells
9. Oxygen-sensing mechanisms are present in the chromaffin cells of the sheep adrenal medulla before birth
10. Adrenomedullary function in the neonatal rat: Responses to acute hypoxia
11. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
12. Carotid body tumors at high altitudes: Quito, Ecuador, 1987
13. First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas)
14. A carotid-body-like tumor on the left subclavian artery
15. Paragangliomas of the head and neck region: A clinical study of 69 patients
16. The incidence of pheochromocytoma in the Netherlands
17. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979
18. Phaeochromocytoma in Queensland 1970-83
19. The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981
20. Incidence of pheochromocytoma in South Galicia, Spain
21. Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data
22. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series
23. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland
24. A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese
25. Benign paragangliomas: Clinical presentation and treatment outcomes in 236 patients
26. Familial carotid body tumors: Case report and epidemiologic review
27. Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory
28. Proportion of heritable PGL cases and associated clinical characteristics
29. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): Natural history, adrenocortical component, and possible familial occurrence
30. Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
31. Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study
32. Functioning carotid paraganglioma in the von Hippel-Lindau syndrome
33. Carotid body paraganglioma in von Hippel-Lindau disease - A rare association
34. Familial pheochromocytoma associated with a novel mutation in the van Hippel-Lindau gene
35. Glomus tumor and multiple endocrine neoplasia
36. Paraganglioma as a systemic syndrome: Pitfalls and strategies
37. Multiple paragangliomas in neurofibromatosis: A new neuroendocrine neoplasia
38. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease
39. Pheochromocytoma: Inherited associations, bilaterality, and cortex preservation
40. Isolated familial pheochromocytoma as a variant of van Hippel-Lindau disease
41. Three-decade investigation of familial pheochromocytoma. An allele of van Hippel-Lindau disease?
42. Molecular genetic diagnosis of van Hippel-Lindau disease in familial phaeochromocytoma
43. Genetic predisposition to phaeochromocytoma: Analysis of candidate genes GDNF, RET and VHL
44. Gene mutations in the succinate dehydrogenase subunit sdhb cause susceptibility to familial pheochromocytoma and to familiar paraganglioma
45. Mutations in SDHC cause autosomal dominant paraganglioma, type 3
46. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
47. Molecular genetics of succinate:quinone oxidoreductase in eukaryotes
48. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter
49. Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma
50. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11 q
51. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
52. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome
53. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene
54. Phenotypic dichotomy in mitochondrial complex II genetic disorders
55. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway
56. Expression of angiogenic growth factors in paragangliomas
57. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23
58. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial porogongliomo
59. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss
60. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene
61. Germline SDHD mutation in familial phaeochromocytoma
62. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas
63. Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands
64. Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
65. PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma
66. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas
67. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas
68. Somatic and MEN 2A de nova mutations identified in the RET proto-oncogene by screening of sporadic MTCs
69. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas
70. The RET protooncogene in sporadic pheochromocytomas: Frequent MEN 2- like mutations and new molecular defects
71. Mutations in the RET proto-oncogene and the van Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas
72. Mutations in the RET protooncogene in sporadic pheochromocytomas
73. Sporadic phaeochromocytomas are rarely associated with germline mutations in the van Hippel-Lindou and RET genes
74. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene
75. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases
76. The RET proto-oncogene in sporadic pheochromocytomas
77. Germ-line mutations in nonsyndromic pheochromocytoma
78. Germline mutations in the vhl gene in patients presenting with phaeochromocytomas
79. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma
80. Primary spinal paragangliomas: A clinicopathological and immunohistochemical study of 30 cases
81. Germline SDHD mutation in poragonglioma of the spinal cord
82. Absence of SDHD mutations in primary nasopharyngeal carcinomas